• FirefoxInstall the new Firefox »
  •  Dow Down 0.42% Nasdaq Down 0.63%

    Insmed Incorporated (INSM)

    -NasdaqGS
    20.83 Up 0.03(0.14%) 1:44PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:20.80
    Open:20.75
    Bid:20.88 x 200
    Ask:20.92 x 500
    1y Target Est:31.14
    Beta:-0.35
    Next Earnings Date:N/A
    Day's Range:20.40 - 20.92
    52wk Range:11.25 - 22.59
    Volume:569,299
    Avg Vol (3m):558,887
    Market Cap:1.04B
    P/E (ttm):N/A
    EPS (ttm):-1.84
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INSMUp 0.14%1.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.11
    Quarterly EPS Est (Mar-15) :-0.50
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing inhaled therapies for patients with serious lung diseases. Its lead product candidate is ARIKAYCE, an inhaled antibiotic treatment that delivers an anti-in... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback